Viking Therapeutics Inc. VKTX announced on Wednesday that it has initiated a Phase 1 trial evaluating VK3019, an ...

On Tuesday, Viking Therapeutics, Inc. (NASDAQ:VKTX) highlighted the final results from its VOYAGE Phase 2b trial of VK2809 in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH, also ...

Just call it history revisited. Viking is setting sail again in China. The Viking Yi Dun completed her first voyage from Shanghai to Hong Kong (Shenzhen). Viking’s new itineraries include a domestic ...

Results from VENTURE Phase 2 Study of Subcutaneous VK2735 in Obese Patients and Phase 1 Trial of Oral VK2735 in Healthy Subjects to be Presented SAN DIEGO, Oct. 28, 2024 /PRNewswire/ -- Viking ...

Notes: 1) Observed values, no imputation for missing data. 2) Includes all participants who met the criteria for MetS at baseline and enough MetS component Week 13 data collected to determine MetS ...

Viking Becomes Main Sponsor for the National Team Academy and Norway’s U-Level National Teams “We believe Norwegian football is entering a new golden age, and we are pleased to be part of the journey.

First, a bit of detail about these products and potential products. Lilly's drugs -- Mounjaro and Zepbound -- involve the molecule tirzepatide, which acts on glucagon-like peptide-1 (GLP-1) and ...